Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Mark Haden, vice president of business development at Clearmind ...

The firm owned 7,085 shares of the biotechnology company’s stock after purchasing an additional 616 shares during the period. M&T Bank Corp’s holdings in BioMarin Pharmaceutical were worth $ ...

Companies developing 505(b)(2), NDA, ANDA, branded or generic prescription drug products are encouraged to explore LGM Pharma’s expanded manufacturing capabilities by visiting LGMPharma.com or ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

Gilead picked the intramuscular route because of the amount of drug needed to be delivered and a better pharmacology profile compared ... according to analyses of samples collected from the ...

This expansion aims to address critical capacity shortages in the US injectable supply chain and meet the growing demand from pharmaceutical companies seeking reliable domestic sterile ...